Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 7.52714272 |
2 | regulation of integrin-mediated signaling pathway (GO:2001044) | 6.58626874 |
3 | thrombin receptor signaling pathway (GO:0070493) | 6.56245486 |
4 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.07818921 |
5 | angiogenesis involved in wound healing (GO:0060055) | 5.99259986 |
6 | ensheathment of neurons (GO:0007272) | 5.70380107 |
7 | axon ensheathment (GO:0008366) | 5.70380107 |
8 | myelination (GO:0042552) | 5.69882532 |
9 | negative regulation of protein localization to cell surface (GO:2000009) | 5.63999232 |
10 | negative regulation of platelet activation (GO:0010544) | 5.44661977 |
11 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.39660231 |
12 | myelin maintenance (GO:0043217) | 5.17023752 |
13 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.16628936 |
14 | regulation of endothelial cell differentiation (GO:0045601) | 5.01899560 |
15 | regulation of platelet aggregation (GO:0090330) | 4.97118699 |
16 | neutrophil activation involved in immune response (GO:0002283) | 4.96160557 |
17 | regulation of platelet activation (GO:0010543) | 4.91698163 |
18 | blood coagulation, intrinsic pathway (GO:0007597) | 4.83944006 |
19 | extracellular fibril organization (GO:0043206) | 4.79683562 |
20 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.79445654 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.76383624 |
22 | platelet aggregation (GO:0070527) | 4.55423398 |
23 | regulation of lipoprotein metabolic process (GO:0050746) | 4.53644503 |
24 | lymph vessel development (GO:0001945) | 4.48408775 |
25 | adenosine receptor signaling pathway (GO:0001973) | 4.45626936 |
26 | amyloid precursor protein metabolic process (GO:0042982) | 4.44494053 |
27 | response to methylmercury (GO:0051597) | 4.41991088 |
28 | platelet degranulation (GO:0002576) | 4.37018211 |
29 | positive regulation of receptor recycling (GO:0001921) | 4.24508223 |
30 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.20441969 |
31 | negative regulation of neurotransmitter transport (GO:0051589) | 4.20096434 |
32 | cholesterol biosynthetic process (GO:0006695) | 4.14949247 |
33 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.06377475 |
34 | creatine metabolic process (GO:0006600) | 4.00590231 |
35 | sequestering of actin monomers (GO:0042989) | 3.93272515 |
36 | negative regulation of norepinephrine secretion (GO:0010700) | 3.89000208 |
37 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.88801924 |
38 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.88334285 |
39 | negative regulation of heart rate (GO:0010459) | 3.88191191 |
40 | fibril organization (GO:0097435) | 3.86285879 |
41 | regulation of collateral sprouting (GO:0048670) | 3.86125030 |
42 | L-amino acid import (GO:0043092) | 3.83912558 |
43 | platelet dense granule organization (GO:0060155) | 3.80513356 |
44 | establishment of mitochondrion localization (GO:0051654) | 3.80097914 |
45 | sterol biosynthetic process (GO:0016126) | 3.80085654 |
46 | blood vessel maturation (GO:0001955) | 3.79767546 |
47 | endothelium development (GO:0003158) | 3.76454693 |
48 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.74555940 |
49 | isoprenoid biosynthetic process (GO:0008299) | 3.71852083 |
50 | negative regulation of appetite (GO:0032099) | 3.70996635 |
51 | negative regulation of response to food (GO:0032096) | 3.70996635 |
52 | protein neddylation (GO:0045116) | 3.70673614 |
53 | eye photoreceptor cell differentiation (GO:0001754) | 3.69780378 |
54 | photoreceptor cell differentiation (GO:0046530) | 3.69780378 |
55 | neuron remodeling (GO:0016322) | 3.68607379 |
56 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.68094274 |
57 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.62906860 |
58 | import into cell (GO:0098657) | 3.59293808 |
59 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.53862575 |
60 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.52143291 |
61 | response to lipoprotein particle (GO:0055094) | 3.50124723 |
62 | GPI anchor biosynthetic process (GO:0006506) | 3.49158157 |
63 | phagocytosis, engulfment (GO:0006911) | 3.44585910 |
64 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.41967640 |
65 | regulation of integrin activation (GO:0033623) | 3.39425102 |
66 | astrocyte development (GO:0014002) | 3.33933409 |
67 | heme transport (GO:0015886) | 3.33700362 |
68 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.32887342 |
69 | extracellular matrix assembly (GO:0085029) | 3.32441022 |
70 | lipoxygenase pathway (GO:0019372) | 3.31289869 |
71 | membrane tubulation (GO:0097320) | 3.30516745 |
72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.29610389 |
73 | platelet activation (GO:0030168) | 3.27703553 |
74 | phospholipid homeostasis (GO:0055091) | 3.27135236 |
75 | limb bud formation (GO:0060174) | 3.23654293 |
76 | regulation of somitogenesis (GO:0014807) | 3.22877052 |
77 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.20937829 |
78 | GPI anchor metabolic process (GO:0006505) | 3.20043520 |
79 | very long-chain fatty acid metabolic process (GO:0000038) | 3.19869458 |
80 | regulation of receptor recycling (GO:0001919) | 3.19152701 |
81 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.18318068 |
82 | membrane invagination (GO:0010324) | 3.14712200 |
83 | positive regulation of blood coagulation (GO:0030194) | 3.13593733 |
84 | positive regulation of hemostasis (GO:1900048) | 3.13593733 |
85 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.11697999 |
86 | oligodendrocyte differentiation (GO:0048709) | 3.08930884 |
87 | neurotransmitter uptake (GO:0001504) | 3.08619738 |
88 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.08345213 |
89 | plasma membrane fusion (GO:0045026) | 3.08047534 |
90 | phospholipid scrambling (GO:0017121) | 3.06416270 |
91 | axon development (GO:0061564) | 3.06115928 |
92 | negative regulation of chemokine production (GO:0032682) | 3.05078104 |
93 | tonic smooth muscle contraction (GO:0014820) | 3.04606728 |
94 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.04277244 |
95 | tissue regeneration (GO:0042246) | 3.03663062 |
96 | positive regulation of pseudopodium assembly (GO:0031274) | 3.03132201 |
97 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.02920823 |
98 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.01614143 |
99 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.01541808 |
100 | enteric nervous system development (GO:0048484) | 3.01449501 |
101 | amyloid precursor protein catabolic process (GO:0042987) | 3.00892340 |
102 | low-density lipoprotein particle remodeling (GO:0034374) | 2.99186851 |
103 | positive regulation of vasculogenesis (GO:2001214) | 2.97335511 |
104 | positive regulation of cell junction assembly (GO:1901890) | 2.96649922 |
105 | positive regulation of focal adhesion assembly (GO:0051894) | 2.96649922 |
106 | response to redox state (GO:0051775) | 2.95424644 |
107 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.94970320 |
108 | glycerophospholipid catabolic process (GO:0046475) | 2.94883088 |
109 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.93976613 |
110 | wound healing, spreading of epidermal cells (GO:0035313) | 2.93400609 |
111 | lymphangiogenesis (GO:0001946) | 2.92214241 |
112 | homotypic cell-cell adhesion (GO:0034109) | 2.91469977 |
113 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.88437409 |
114 | megakaryocyte development (GO:0035855) | 2.88364297 |
115 | autophagic vacuole fusion (GO:0000046) | 2.88218825 |
116 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.87274178 |
117 | sodium-independent organic anion transport (GO:0043252) | 2.87217961 |
118 | amino acid import (GO:0043090) | 2.86752041 |
119 | positive regulation of muscle hypertrophy (GO:0014742) | 2.85747738 |
120 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.85747738 |
121 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.85342590 |
122 | positive regulation of macrophage differentiation (GO:0045651) | 2.84499508 |
123 | potassium ion import (GO:0010107) | 2.84015825 |
124 | iron coordination entity transport (GO:1901678) | 2.83153897 |
125 | protein palmitoylation (GO:0018345) | 2.82961896 |
126 | polyamine biosynthetic process (GO:0006596) | 2.82037244 |
127 | regulation of sensory perception of pain (GO:0051930) | 2.81950416 |
128 | regulation of sensory perception (GO:0051931) | 2.81950416 |
129 | membrane raft organization (GO:0031579) | 2.81545144 |
130 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.81411317 |
131 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.80439955 |
132 | positive regulation of glial cell differentiation (GO:0045687) | 2.79501527 |
133 | regulation of blood coagulation (GO:0030193) | 2.78811277 |
134 | regulation of hemostasis (GO:1900046) | 2.78811277 |
135 | regulation of metalloenzyme activity (GO:0048552) | 2.77708525 |
136 | negative regulation of hemostasis (GO:1900047) | 2.77084779 |
137 | negative regulation of blood coagulation (GO:0030195) | 2.77084779 |
138 | platelet formation (GO:0030220) | 2.77045918 |
139 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.76369914 |
140 | negative regulation of coagulation (GO:0050819) | 2.76285075 |
141 | positive regulation of coagulation (GO:0050820) | 2.75719723 |
142 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.75174314 |
143 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.75032755 |
144 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.73627077 |
145 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.73627077 |
146 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.71802777 |
147 | beta-amyloid metabolic process (GO:0050435) | 2.71773266 |
148 | phagocytosis, recognition (GO:0006910) | 2.71730105 |
149 | substantia nigra development (GO:0021762) | 2.70059719 |
150 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.69037346 |
151 | regulation of vasculogenesis (GO:2001212) | 2.68884747 |
152 | mannosylation (GO:0097502) | 2.67920914 |
153 | sprouting angiogenesis (GO:0002040) | 2.67436874 |
154 | regulation of coagulation (GO:0050818) | 2.67386856 |
155 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.66441542 |
156 | heart process (GO:0003015) | 2.66402444 |
157 | heart contraction (GO:0060047) | 2.66402444 |
158 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.64849319 |
159 | regulation of pseudopodium assembly (GO:0031272) | 2.64337984 |
160 | positive regulation of adherens junction organization (GO:1903393) | 2.64315031 |
161 | magnesium ion transport (GO:0015693) | 2.62718011 |
162 | asymmetric protein localization (GO:0008105) | 2.61409956 |
163 | mesodermal cell differentiation (GO:0048333) | 2.57112908 |
164 | presynaptic membrane organization (GO:0097090) | 2.56568258 |
165 | peripheral nervous system axon ensheathment (GO:0032292) | 2.56004717 |
166 | myelination in peripheral nervous system (GO:0022011) | 2.56004717 |
167 | positive regulation of gliogenesis (GO:0014015) | 2.55570999 |
168 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.54745331 |
169 | glycosylceramide metabolic process (GO:0006677) | 2.51814321 |
170 | response to lead ion (GO:0010288) | 2.51808332 |
171 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.49824113 |
172 | organ growth (GO:0035265) | 2.48451633 |
173 | apical protein localization (GO:0045176) | 2.47439754 |
174 | glomerular filtration (GO:0003094) | 2.44906169 |
175 | copper ion homeostasis (GO:0055070) | 2.44032907 |
176 | cellular copper ion homeostasis (GO:0006878) | 2.41723079 |
177 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.40815873 |
178 | neuron fate determination (GO:0048664) | 2.40143946 |
179 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.37465691 |
180 | virion attachment to host cell (GO:0019062) | 2.32734914 |
181 | adhesion of symbiont to host cell (GO:0044650) | 2.32734914 |
182 | negative regulation of adherens junction organization (GO:1903392) | 2.32308167 |
183 | negative regulation of focal adhesion assembly (GO:0051895) | 2.32308167 |
184 | negative regulation of cell junction assembly (GO:1901889) | 2.32308167 |
185 | regulation of pigment cell differentiation (GO:0050932) | 2.31538822 |
186 | central nervous system myelination (GO:0022010) | 11.8513980 |
187 | axon ensheathment in central nervous system (GO:0032291) | 11.8513980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.45498984 |
2 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.52126254 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49498815 |
4 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.41814069 |
5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.40248106 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34265627 |
7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29282858 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25176955 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.19230208 |
10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16981662 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06311302 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04782440 |
13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.03918189 |
14 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.98787767 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97254059 |
16 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.94027069 |
17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.93808585 |
18 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.93590590 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91240591 |
20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91141442 |
21 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.90162555 |
22 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88970385 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87554964 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86273453 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86273453 |
26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85569964 |
27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83424374 |
28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76937987 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.75685969 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75256221 |
31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.75198124 |
32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.75198124 |
33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72703380 |
34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.71864851 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71844770 |
36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.70658496 |
37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69683958 |
38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.69231420 |
39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64307678 |
40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62816970 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62758090 |
42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61632537 |
43 | GATA2_19941826_ChIP-Seq_K562_Human | 1.61527731 |
44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58055464 |
45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54434368 |
46 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.52124563 |
47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50701985 |
48 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.49563366 |
49 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.49251982 |
50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47799169 |
51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46721921 |
52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46105217 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44785826 |
54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41281947 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38451867 |
56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38417377 |
57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36557732 |
58 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36372895 |
59 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.35306657 |
60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33004761 |
61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32535647 |
62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32380768 |
63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30571131 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29711980 |
65 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29523112 |
66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29509289 |
67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28372951 |
68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27560165 |
69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26027277 |
70 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25900125 |
71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23050769 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21415517 |
73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20261189 |
74 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.19720000 |
75 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19253140 |
76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19203926 |
77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18193069 |
78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18131085 |
79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17257186 |
80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16989286 |
81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16793036 |
82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16149560 |
83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16136499 |
84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14994243 |
85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14766796 |
86 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12785094 |
87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12652514 |
88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.12335434 |
89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11340849 |
90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10688696 |
91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09223364 |
92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09153140 |
93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08900320 |
94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06909551 |
95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06814113 |
96 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06075418 |
97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05511670 |
98 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04953581 |
99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04500057 |
100 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03341167 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03125407 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01427298 |
103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01255516 |
104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00598774 |
105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00176204 |
106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99525348 |
107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99284329 |
108 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98320344 |
109 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97657518 |
110 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96882995 |
111 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96882995 |
112 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96882995 |
113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96419242 |
114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96338026 |
115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96189079 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95985328 |
117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95757724 |
118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94369719 |
119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93191764 |
120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93187549 |
121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92742135 |
122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92664337 |
123 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92443786 |
124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92177851 |
125 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91953460 |
126 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91749934 |
127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91735867 |
128 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91729157 |
129 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91275991 |
130 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90481266 |
131 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90299700 |
132 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90144199 |
133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90049352 |
134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89752154 |
135 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89396865 |
136 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88981443 |
137 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88981443 |
138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88160597 |
139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86041955 |
140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85155237 |
141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84964154 |
142 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84403056 |
143 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84292741 |
144 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83748625 |
145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83453784 |
146 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83310666 |
147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83105291 |
148 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83048945 |
149 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81914241 |
150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81088699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 6.63167940 |
2 | MP0003950_abnormal_plasma_membrane | 4.77659911 |
3 | MP0000920_abnormal_myelination | 4.71555300 |
4 | MP0008004_abnormal_stomach_pH | 4.51230939 |
5 | MP0001879_abnormal_lymphatic_vessel | 3.24917729 |
6 | MP0010368_abnormal_lymphatic_system | 3.22971281 |
7 | MP0005171_absent_coat_pigmentation | 3.22610756 |
8 | MP0004147_increased_porphyrin_level | 3.12538435 |
9 | MP0003566_abnormal_cell_adhesion | 2.87260886 |
10 | MP0005409_darkened_coat_color | 2.80145832 |
11 | MP0009379_abnormal_foot_pigmentation | 2.56623625 |
12 | MP0005167_abnormal_blood-brain_barrier | 2.53630107 |
13 | MP0000343_altered_response_to | 2.51149242 |
14 | MP0004272_abnormal_basement_membrane | 2.47494973 |
15 | MP0005623_abnormal_meninges_morphology | 2.41003071 |
16 | MP0003136_yellow_coat_color | 2.38276262 |
17 | MP0003690_abnormal_glial_cell | 2.36567903 |
18 | MP0008438_abnormal_cutaneous_collagen | 2.01563788 |
19 | MP0003880_abnormal_central_pattern | 2.00015767 |
20 | MP0001905_abnormal_dopamine_level | 1.90404114 |
21 | MP0003724_increased_susceptibility_to | 1.89092545 |
22 | MP0004742_abnormal_vestibular_system | 1.78891343 |
23 | MP0002295_abnormal_pulmonary_circulatio | 1.71791628 |
24 | MP0004043_abnormal_pH_regulation | 1.63858359 |
25 | MP0005083_abnormal_biliary_tract | 1.63517772 |
26 | MP0004510_myositis | 1.62786714 |
27 | MP0004142_abnormal_muscle_tone | 1.62623657 |
28 | MP0005408_hypopigmentation | 1.61451529 |
29 | MP0004270_analgesia | 1.59965215 |
30 | MP0003634_abnormal_glial_cell | 1.59595739 |
31 | MP0009697_abnormal_copulation | 1.59033692 |
32 | MP0004036_abnormal_muscle_relaxation | 1.57640931 |
33 | MP0002736_abnormal_nociception_after | 1.57398599 |
34 | MP0005410_abnormal_fertilization | 1.56797522 |
35 | MP0004885_abnormal_endolymph | 1.54592092 |
36 | MP0001486_abnormal_startle_reflex | 1.53900170 |
37 | MP0002877_abnormal_melanocyte_morpholog | 1.53816106 |
38 | MP0001529_abnormal_vocalization | 1.53581639 |
39 | MP0003303_peritoneal_inflammation | 1.44668991 |
40 | MP0003633_abnormal_nervous_system | 1.43883219 |
41 | MP0005423_abnormal_somatic_nervous | 1.43721996 |
42 | MP0000767_abnormal_smooth_muscle | 1.41797203 |
43 | MP0005275_abnormal_skin_tensile | 1.40395735 |
44 | MP0002272_abnormal_nervous_system | 1.39205829 |
45 | MP0003329_amyloid_beta_deposits | 1.38922648 |
46 | MP0005165_increased_susceptibility_to | 1.38301377 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.37958233 |
48 | MP0004381_abnormal_hair_follicle | 1.37439531 |
49 | MP0001485_abnormal_pinna_reflex | 1.36393671 |
50 | MP0000749_muscle_degeneration | 1.36135270 |
51 | MP0003631_nervous_system_phenotype | 1.34916529 |
52 | MP0009384_cardiac_valve_regurgitation | 1.31276272 |
53 | MP0010678_abnormal_skin_adnexa | 1.31043993 |
54 | MP0004484_altered_response_of | 1.30890177 |
55 | MP0000372_irregular_coat_pigmentation | 1.30648604 |
56 | MP0004134_abnormal_chest_morphology | 1.30162556 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.29537636 |
58 | MP0005595_abnormal_vascular_smooth | 1.28286800 |
59 | MP0000462_abnormal_digestive_system | 1.27901610 |
60 | MP0005164_abnormal_response_to | 1.26831679 |
61 | MP0006054_spinal_hemorrhage | 1.24024264 |
62 | MP0003632_abnormal_nervous_system | 1.22098530 |
63 | MP0003638_abnormal_response/metabolism_ | 1.20833838 |
64 | MP0001544_abnormal_cardiovascular_syste | 1.20644018 |
65 | MP0005385_cardiovascular_system_phenoty | 1.20644018 |
66 | MP0002938_white_spotting | 1.20315412 |
67 | MP0001851_eye_inflammation | 1.17196218 |
68 | MP0005084_abnormal_gallbladder_morpholo | 1.15638134 |
69 | MP0000383_abnormal_hair_follicle | 1.15571963 |
70 | MP0000762_abnormal_tongue_morphology | 1.13498802 |
71 | MP0004130_abnormal_muscle_cell | 1.13449057 |
72 | MP0003091_abnormal_cell_migration | 1.12269682 |
73 | MP0001958_emphysema | 1.10959265 |
74 | MP0001915_intracranial_hemorrhage | 1.10827078 |
75 | MP0006138_congestive_heart_failure | 1.10453727 |
76 | MP0003279_aneurysm | 1.10222553 |
77 | MP0005023_abnormal_wound_healing | 1.09617788 |
78 | MP0005551_abnormal_eye_electrophysiolog | 1.08729460 |
79 | MP0010030_abnormal_orbit_morphology | 1.07843036 |
80 | MP0003011_delayed_dark_adaptation | 1.01117484 |
81 | MP0002229_neurodegeneration | 1.00988503 |
82 | MP0001346_abnormal_lacrimal_gland | 1.00666154 |
83 | MP0000778_abnormal_nervous_system | 1.00511872 |
84 | MP0003195_calcinosis | 0.99802676 |
85 | MP0005330_cardiomyopathy | 0.97722518 |
86 | MP0005187_abnormal_penis_morphology | 0.96673539 |
87 | MP0004084_abnormal_cardiac_muscle | 0.95611533 |
88 | MP0009250_abnormal_appendicular_skeleto | 0.95006015 |
89 | MP0004145_abnormal_muscle_electrophysio | 0.93033796 |
90 | MP0006276_abnormal_autonomic_nervous | 0.91616288 |
91 | MP0000747_muscle_weakness | 0.90127957 |
92 | MP0001614_abnormal_blood_vessel | 0.90064983 |
93 | MP0005195_abnormal_posterior_eye | 0.89901969 |
94 | MP0009053_abnormal_anal_canal | 0.89816808 |
95 | MP0004215_abnormal_myocardial_fiber | 0.89265160 |
96 | MP0005388_respiratory_system_phenotype | 0.88864712 |
97 | MP0002133_abnormal_respiratory_system | 0.88864712 |
98 | MP0002064_seizures | 0.88312849 |
99 | MP0002972_abnormal_cardiac_muscle | 0.88067647 |
100 | MP0005058_abnormal_lysosome_morphology | 0.86565608 |
101 | MP0005451_abnormal_body_composition | 0.86502784 |
102 | MP0008260_abnormal_autophagy | 0.85576102 |
103 | MP0004085_abnormal_heartbeat | 0.84114799 |
104 | MP0005620_abnormal_muscle_contractility | 0.83906513 |
105 | MP0003137_abnormal_impulse_conducting | 0.83141814 |
106 | MP0002009_preneoplasia | 0.83115189 |
107 | MP0009780_abnormal_chondrocyte_physiolo | 0.82963671 |
108 | MP0005670_abnormal_white_adipose | 0.82790304 |
109 | MP0001661_extended_life_span | 0.82151538 |
110 | MP0003828_pulmonary_edema | 0.81452742 |
111 | MP0005503_abnormal_tendon_morphology | 0.81227454 |
112 | MP0008569_lethality_at_weaning | 0.80491354 |
113 | MP0001542_abnormal_bone_strength | 0.78488809 |
114 | MP0000647_abnormal_sebaceous_gland | 0.77848683 |
115 | MP0000230_abnormal_systemic_arterial | 0.75923392 |
116 | MP0004883_abnormal_blood_vessel | 0.74905291 |
117 | MP0002249_abnormal_larynx_morphology | 0.74457761 |
118 | MP0008872_abnormal_physiological_respon | 0.74181530 |
119 | MP0002108_abnormal_muscle_morphology | 0.72675506 |
120 | MP0001663_abnormal_digestive_system | 0.72125850 |
121 | MP0010329_abnormal_lipoprotein_level | 0.71645861 |
122 | MP0001963_abnormal_hearing_physiology | 0.71284831 |
123 | MP0003186_abnormal_redox_activity | 0.71251459 |
124 | MP0009764_decreased_sensitivity_to | 0.70802314 |
125 | MP0005508_abnormal_skeleton_morphology | 0.68576664 |
126 | MP0008874_decreased_physiological_sensi | 0.67974407 |
127 | MP0003938_abnormal_ear_development | 0.67640600 |
128 | MP0008775_abnormal_heart_ventricle | 0.66568404 |
129 | MP0002332_abnormal_exercise_endurance | 0.66349975 |
130 | MP0000249_abnormal_blood_vessel | 0.66051267 |
131 | MP0000163_abnormal_cartilage_morphology | 0.64836975 |
132 | MP0002127_abnormal_cardiovascular_syste | 0.64580111 |
133 | MP0002925_abnormal_cardiovascular_devel | 0.63523470 |
134 | MP0003705_abnormal_hypodermis_morpholog | 0.62897141 |
135 | MP0002128_abnormal_blood_circulation | 0.62762613 |
136 | MP0002734_abnormal_mechanical_nocicepti | 0.62689379 |
137 | MP0002933_joint_inflammation | 0.62400059 |
138 | MP0001188_hyperpigmentation | 0.62136424 |
139 | MP0001784_abnormal_fluid_regulation | 0.60981459 |
140 | MP0000358_abnormal_cell_content/ | 0.60804544 |
141 | MP0000049_abnormal_middle_ear | 0.60115441 |
142 | MP0000858_altered_metastatic_potential | 0.59929312 |
143 | MP0002733_abnormal_thermal_nociception | 0.57988469 |
144 | MP0009763_increased_sensitivity_to | 0.57492971 |
145 | MP0001968_abnormal_touch/_nociception | 0.57149774 |
146 | MP0005390_skeleton_phenotype | 0.56081338 |
147 | MP0003300_gastrointestinal_ulcer | 0.55805726 |
148 | MP0005248_abnormal_Harderian_gland | 0.55733615 |
149 | MP0001533_abnormal_skeleton_physiology | 0.53726922 |
150 | MP0010155_abnormal_intestine_physiology | 0.53252287 |
151 | MP0002138_abnormal_hepatobiliary_system | 0.51257221 |
152 | MP0000015_abnormal_ear_pigmentation | 0.48206245 |
153 | MP0002132_abnormal_respiratory_system | 0.47703154 |
154 | MP0003448_altered_tumor_morphology | 0.46933795 |
155 | MP0005666_abnormal_adipose_tissue | 0.46464574 |
156 | MP0002113_abnormal_skeleton_development | 0.45374309 |
157 | MP0005085_abnormal_gallbladder_physiolo | 0.44539763 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 9.60025277 |
2 | Increased mean platelet volume (HP:0011877) | 9.58204213 |
3 | Abnormal platelet volume (HP:0011876) | 8.78436303 |
4 | Petechiae (HP:0000967) | 7.79582380 |
5 | Purpura (HP:0000979) | 7.12624093 |
6 | Epistaxis (HP:0000421) | 6.51438490 |
7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.65271114 |
8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.65271114 |
9 | Neurofibrillary tangles (HP:0002185) | 5.61176445 |
10 | Spontaneous hematomas (HP:0007420) | 5.53157611 |
11 | Abnormal platelet function (HP:0011869) | 5.32654760 |
12 | Impaired platelet aggregation (HP:0003540) | 5.32654760 |
13 | Conjunctival telangiectasia (HP:0000524) | 5.25445283 |
14 | Gingival bleeding (HP:0000225) | 4.63857050 |
15 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 4.30423591 |
16 | Dyschromatopsia (HP:0007641) | 4.10543535 |
17 | Parakeratosis (HP:0001036) | 4.09804441 |
18 | Onion bulb formation (HP:0003383) | 3.88747905 |
19 | Peripheral hypomyelination (HP:0007182) | 3.86952314 |
20 | Cerebral hemorrhage (HP:0001342) | 3.75153576 |
21 | Cerebral inclusion bodies (HP:0100314) | 3.66713377 |
22 | Abnormality of the corticospinal tract (HP:0002492) | 3.61021952 |
23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.54463081 |
24 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.46123116 |
25 | Polycythemia (HP:0001901) | 3.29485417 |
26 | Retinal dysplasia (HP:0007973) | 3.27766458 |
27 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.25365577 |
28 | Aortic aneurysm (HP:0004942) | 3.21806885 |
29 | Hypoplasia of the iris (HP:0007676) | 3.14355979 |
30 | Bruising susceptibility (HP:0000978) | 3.13528544 |
31 | Abnormality of glycolysis (HP:0004366) | 3.06673333 |
32 | Increased serum pyruvate (HP:0003542) | 3.06673333 |
33 | Stridor (HP:0010307) | 3.06633076 |
34 | Abnormal auditory evoked potentials (HP:0006958) | 3.06567507 |
35 | Abnormal pupillary function (HP:0007686) | 3.03055159 |
36 | Myocardial infarction (HP:0001658) | 3.01435824 |
37 | Leukodystrophy (HP:0002415) | 2.93148804 |
38 | Stenosis of the external auditory canal (HP:0000402) | 2.92541552 |
39 | Aortic dissection (HP:0002647) | 2.90828542 |
40 | Insidious onset (HP:0003587) | 2.89693902 |
41 | Termporal pattern (HP:0011008) | 2.89693902 |
42 | Increased density of long bones (HP:0006392) | 2.88378913 |
43 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.88052036 |
44 | Muscle fiber splitting (HP:0003555) | 2.88037030 |
45 | Scanning speech (HP:0002168) | 2.85258152 |
46 | Acanthocytosis (HP:0001927) | 2.80229731 |
47 | Sensory axonal neuropathy (HP:0003390) | 2.77815406 |
48 | Poikilocytosis (HP:0004447) | 2.70354574 |
49 | Short hallux (HP:0010109) | 2.69748703 |
50 | Renal Fanconi syndrome (HP:0001994) | 2.61935272 |
51 | Patchy hypopigmentation of hair (HP:0011365) | 2.61790596 |
52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59842509 |
53 | Protrusio acetabuli (HP:0003179) | 2.59460552 |
54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.57969218 |
55 | Anteriorly placed anus (HP:0001545) | 2.53671878 |
56 | Diaphragmatic weakness (HP:0009113) | 2.53193481 |
57 | Supranuclear gaze palsy (HP:0000605) | 2.52430230 |
58 | Premature skin wrinkling (HP:0100678) | 2.51083258 |
59 | Axonal loss (HP:0003447) | 2.48166477 |
60 | Clumsiness (HP:0002312) | 2.44544017 |
61 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.42811044 |
62 | Metabolic alkalosis (HP:0200114) | 2.39387700 |
63 | Tetraparesis (HP:0002273) | 2.37150280 |
64 | White forelock (HP:0002211) | 2.37004488 |
65 | Ankle clonus (HP:0011448) | 2.34542510 |
66 | Slow saccadic eye movements (HP:0000514) | 2.34133118 |
67 | Cerebral hypomyelination (HP:0006808) | 2.31222804 |
68 | Acute necrotizing encephalopathy (HP:0006965) | 2.30968499 |
69 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.27867276 |
70 | Absent septum pellucidum (HP:0001331) | 2.26496665 |
71 | Broad metatarsal (HP:0001783) | 2.25325553 |
72 | Hypoplastic left heart (HP:0004383) | 2.24258988 |
73 | Spastic gait (HP:0002064) | 2.23679524 |
74 | Hematochezia (HP:0002573) | 2.21060111 |
75 | Joint hemorrhage (HP:0005261) | 2.19026710 |
76 | Vascular tortuosity (HP:0004948) | 2.18580284 |
77 | Hepatosplenomegaly (HP:0001433) | 2.18394127 |
78 | Foot dorsiflexor weakness (HP:0009027) | 2.18160699 |
79 | Alacrima (HP:0000522) | 2.17858548 |
80 | Esophageal atresia (HP:0002032) | 2.17804751 |
81 | Partial duplication of thumb phalanx (HP:0009944) | 2.17793962 |
82 | 3-Methylglutaconic aciduria (HP:0003535) | 2.17136962 |
83 | Nausea (HP:0002018) | 2.17082703 |
84 | Mitral stenosis (HP:0001718) | 2.16600712 |
85 | Intention tremor (HP:0002080) | 2.15087105 |
86 | Autoamputation (HP:0001218) | 2.14995001 |
87 | Thickened helices (HP:0000391) | 2.14883315 |
88 | Coronal craniosynostosis (HP:0004440) | 2.14371399 |
89 | Spinal rigidity (HP:0003306) | 2.13998117 |
90 | Premature rupture of membranes (HP:0001788) | 2.13707142 |
91 | Arterial tortuosity (HP:0005116) | 2.13245419 |
92 | Infantile muscular hypotonia (HP:0008947) | 2.12118469 |
93 | Dysmetria (HP:0001310) | 2.11607883 |
94 | Gowers sign (HP:0003391) | 2.11036940 |
95 | Hypokalemic alkalosis (HP:0001949) | 2.10666113 |
96 | Hyporeflexia of lower limbs (HP:0002600) | 2.09180314 |
97 | Dysautonomia (HP:0002459) | 2.07520645 |
98 | Hypomagnesemia (HP:0002917) | 2.07374819 |
99 | Paralysis (HP:0003470) | 2.06454608 |
100 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06402356 |
101 | Mucosal telangiectasiae (HP:0100579) | 2.05937748 |
102 | Methylmalonic acidemia (HP:0002912) | 2.05134603 |
103 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03778143 |
104 | Aplasia involving bones of the extremities (HP:0009825) | 2.03778143 |
105 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03778143 |
106 | Hemiparesis (HP:0001269) | 2.03422304 |
107 | Xanthomatosis (HP:0000991) | 2.03259920 |
108 | Abnormality of the foot musculature (HP:0001436) | 2.01087899 |
109 | Decreased central vision (HP:0007663) | 2.00609977 |
110 | Menorrhagia (HP:0000132) | 10.0838036 |
111 | Acute encephalopathy (HP:0006846) | 1.98613374 |
112 | Partial duplication of the phalanx of hand (HP:0009999) | 1.98523541 |
113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98418671 |
114 | Portal hypertension (HP:0001409) | 1.98105589 |
115 | Pulmonary artery stenosis (HP:0004415) | 1.94175596 |
116 | Abnormality of lateral ventricle (HP:0030047) | 1.93689374 |
117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93625121 |
118 | Upper limb muscle weakness (HP:0003484) | 1.93477662 |
119 | Increased circulating renin level (HP:0000848) | 1.91311660 |
120 | Ankyloglossia (HP:0010296) | 1.91153334 |
121 | Mitochondrial inheritance (HP:0001427) | 1.89932451 |
122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.89543634 |
123 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89284677 |
124 | Ileus (HP:0002595) | 1.88574004 |
125 | Abnormality of the axillary hair (HP:0100134) | 1.87405004 |
126 | Abnormality of secondary sexual hair (HP:0009888) | 1.87405004 |
127 | Confusion (HP:0001289) | 1.87181937 |
128 | Hyperlipoproteinemia (HP:0010980) | 1.86941994 |
129 | Buphthalmos (HP:0000557) | 1.86660577 |
130 | Steppage gait (HP:0003376) | 1.86460497 |
131 | Spastic paraparesis (HP:0002313) | 1.86370145 |
132 | Exertional dyspnea (HP:0002875) | 1.86349297 |
133 | Progressive macrocephaly (HP:0004481) | 1.84682803 |
134 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84534878 |
135 | Split foot (HP:0001839) | 1.84384747 |
136 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.83586929 |
137 | Hypoplasia of the fovea (HP:0007750) | 1.83586929 |
138 | Hammertoe (HP:0001765) | 1.83196188 |
139 | Abnormality of the septum pellucidum (HP:0007375) | 1.83168679 |
140 | Morphological abnormality of the inner ear (HP:0011390) | 1.82030591 |
141 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80702177 |
142 | Hypoplastic pelvis (HP:0008839) | 1.80582378 |
143 | Prolonged neonatal jaundice (HP:0006579) | 1.80553632 |
144 | CNS hypomyelination (HP:0003429) | 1.79787988 |
145 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79749034 |
146 | Abnormality of the fovea (HP:0000493) | 1.79318622 |
147 | Hepatocellular necrosis (HP:0001404) | 1.77938929 |
148 | Back pain (HP:0003418) | 1.76776373 |
149 | Nonprogressive disorder (HP:0003680) | 1.76426813 |
150 | Hypoplastic heart (HP:0001961) | 1.76209256 |
151 | Abnormality of the hepatic vasculature (HP:0006707) | 1.76120266 |
152 | Biliary tract neoplasm (HP:0100574) | 1.75537969 |
153 | Generalized aminoaciduria (HP:0002909) | 1.70462481 |
154 | Venous insufficiency (HP:0005293) | 1.69420191 |
155 | Scotoma (HP:0000575) | 1.68568982 |
156 | Testicular neoplasm (HP:0010788) | 1.65659015 |
157 | Soft skin (HP:0000977) | 1.60621477 |
158 | Gonadal dysgenesis (HP:0000133) | 1.58942439 |
159 | Abnormality of oral frenula (HP:0000190) | 1.56517590 |
160 | Congenital sensorineural hearing impairment (HP:0008527) | 1.52826992 |
161 | Cardiovascular calcification (HP:0011915) | 1.52776503 |
162 | Peritonitis (HP:0002586) | 1.50845156 |
163 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.50404548 |
164 | Neoplasm of the rectum (HP:0100743) | 1.48421962 |
165 | Thyroid-stimulating hormone excess (HP:0002925) | 1.48361633 |
166 | Hypophosphatemic rickets (HP:0004912) | 1.48038022 |
167 | Venous abnormality (HP:0002624) | 1.46830618 |
168 | Spontaneous abortion (HP:0005268) | 1.46648853 |
169 | Choroideremia (HP:0001139) | 1.46141930 |
170 | Esophageal varix (HP:0002040) | 1.45965199 |
171 | Muscle fibrillation (HP:0010546) | 1.45703634 |
172 | Blue sclerae (HP:0000592) | 1.45199611 |
173 | Renal tubular acidosis (HP:0001947) | 1.41269328 |
174 | Follicular hyperkeratosis (HP:0007502) | 1.39140933 |
175 | Disproportionate short-trunk short stature (HP:0003521) | 1.38802716 |
176 | Abnormal ciliary motility (HP:0012262) | 1.38342832 |
177 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.38088118 |
178 | Uterine leiomyosarcoma (HP:0002891) | 1.37365967 |
179 | Leiomyosarcoma (HP:0100243) | 1.37365967 |
180 | Vascular calcification (HP:0004934) | 1.36781757 |
181 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.36029653 |
182 | Papillary thyroid carcinoma (HP:0002895) | 1.35552483 |
183 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.35393006 |
184 | Distal lower limb amyotrophy (HP:0008944) | 1.34886968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.75458436 |
2 | MAPKAPK5 | 3.94121710 |
3 | TIE1 | 3.82310797 |
4 | EPHB1 | 3.66427503 |
5 | OXSR1 | 3.59903962 |
6 | BMX | 2.73665179 |
7 | KDR | 2.66691767 |
8 | PBK | 2.64516194 |
9 | PKN1 | 2.53546679 |
10 | EIF2AK1 | 2.40320584 |
11 | RIPK4 | 2.28219809 |
12 | FGFR2 | 2.20217904 |
13 | MST4 | 2.18361960 |
14 | MUSK | 2.16745176 |
15 | MAP3K12 | 2.09713656 |
16 | MET | 2.09485088 |
17 | GRK5 | 2.08162945 |
18 | PLK2 | 2.00868646 |
19 | STK10 | 1.96636275 |
20 | WNK4 | 1.93083746 |
21 | TESK2 | 1.85370714 |
22 | BCR | 1.80614136 |
23 | ADRBK1 | 1.72046563 |
24 | FER | 1.69399050 |
25 | CLK1 | 1.65881642 |
26 | BTK | 1.53106626 |
27 | TRIM28 | 1.52999300 |
28 | GRK1 | 1.47241416 |
29 | MYLK | 1.45367900 |
30 | LIMK1 | 1.44529210 |
31 | ZAP70 | 1.38981909 |
32 | SIK3 | 1.38104286 |
33 | CAMK2B | 1.37211513 |
34 | MAPKAPK3 | 1.35022197 |
35 | CSNK1G3 | 1.33254704 |
36 | FGR | 1.30145486 |
37 | CSNK1A1L | 1.29849366 |
38 | UHMK1 | 1.29471791 |
39 | ROCK2 | 1.27806309 |
40 | LRRK2 | 1.26199852 |
41 | TGFBR1 | 1.24752400 |
42 | BMPR2 | 1.24620230 |
43 | CAMK2D | 1.24389370 |
44 | PTK2B | 1.24156883 |
45 | STK3 | 1.23552249 |
46 | ROCK1 | 1.23508885 |
47 | WNK1 | 1.18221043 |
48 | PRKD1 | 1.18113614 |
49 | CDK19 | 1.17850597 |
50 | NTRK1 | 1.15763254 |
51 | ACVR1B | 1.14592530 |
52 | BMPR1B | 1.13577171 |
53 | DYRK2 | 1.09461634 |
54 | CSNK1G1 | 1.06861223 |
55 | MAPK15 | 1.06708289 |
56 | TNIK | 1.04509879 |
57 | NEK6 | 1.04191485 |
58 | PIK3CA | 1.04141838 |
59 | MARK2 | 1.03402033 |
60 | MAP2K2 | 1.01575269 |
61 | PRKG2 | 1.01202547 |
62 | TGFBR2 | 0.98986147 |
63 | ARAF | 0.97897154 |
64 | CSF1R | 0.93908626 |
65 | CAMK2G | 0.92504800 |
66 | MKNK1 | 0.91071240 |
67 | CASK | 0.89747513 |
68 | SGK223 | 0.88602874 |
69 | SGK494 | 0.88602874 |
70 | CSNK1G2 | 0.86597450 |
71 | PAK2 | 0.86326416 |
72 | PRKCE | 0.84625882 |
73 | PAK3 | 0.84438597 |
74 | PNCK | 0.84200751 |
75 | CAMK2A | 0.80087942 |
76 | TESK1 | 0.80032633 |
77 | GRK6 | 0.79850712 |
78 | MAPK12 | 0.79074077 |
79 | RPS6KA5 | 0.76669972 |
80 | SYK | 0.75826809 |
81 | PTK2 | 0.75030767 |
82 | PIM2 | 0.74769654 |
83 | HCK | 0.74360935 |
84 | LMTK2 | 0.73795871 |
85 | TRPM7 | 0.72327616 |
86 | CSK | 0.68882985 |
87 | ERBB4 | 0.66239401 |
88 | PRKD2 | 0.65540877 |
89 | OBSCN | 0.64998844 |
90 | GSK3A | 0.64866177 |
91 | NUAK1 | 0.63912740 |
92 | PRKG1 | 0.62546572 |
93 | DAPK3 | 0.62525150 |
94 | MAP2K3 | 0.62357003 |
95 | CDK8 | 0.61785249 |
96 | PRKCQ | 0.60212087 |
97 | MAP3K3 | 0.58250020 |
98 | CAMK1G | 0.58135756 |
99 | MAP2K1 | 0.58042931 |
100 | YES1 | 0.57688873 |
101 | PRKACB | 0.56280473 |
102 | PHKG1 | 0.56225520 |
103 | PHKG2 | 0.56225520 |
104 | DMPK | 0.55637573 |
105 | PAK4 | 0.53823374 |
106 | ERBB3 | 0.52880858 |
107 | NEK9 | 0.52673079 |
108 | ILK | 0.51851200 |
109 | KIT | 0.51154719 |
110 | MINK1 | 0.50812916 |
111 | MAPK13 | 0.50480784 |
112 | TLK1 | 0.50462005 |
113 | IRAK1 | 0.47590495 |
114 | IGF1R | 0.46794861 |
115 | INSRR | 0.46589480 |
116 | MAPK7 | 0.46479299 |
117 | FLT3 | 0.45968210 |
118 | INSR | 0.44931583 |
119 | PLK3 | 0.43427164 |
120 | ITK | 0.43213905 |
121 | NLK | 0.42789781 |
122 | CDK14 | 0.42129480 |
123 | MAP3K5 | 0.41925159 |
124 | ERBB2 | 0.40940280 |
125 | ADRBK2 | 0.40699538 |
126 | WEE1 | 0.40467111 |
127 | PIK3CG | 0.40362590 |
128 | TAOK3 | 0.39867119 |
129 | NME2 | 0.39477411 |
130 | LYN | 0.39435052 |
131 | CDK5 | 0.38847519 |
132 | GRK7 | 0.38488887 |
133 | DYRK3 | 0.37624699 |
134 | DDR2 | 0.37270173 |
135 | BRSK2 | 0.36751654 |
136 | FYN | 0.36581766 |
137 | EPHB2 | 0.36466055 |
138 | MAPK4 | 0.36103323 |
139 | PDPK1 | 0.35650895 |
140 | VRK1 | 0.35096453 |
141 | MARK3 | 0.35057035 |
142 | PRKACG | 0.33417251 |
143 | CAMK1 | 0.33103751 |
144 | PRKAA2 | 0.32684958 |
145 | TEC | 0.32639415 |
146 | PDGFRA | 0.32547689 |
147 | MOS | 0.31840915 |
148 | PAK1 | 0.31584780 |
149 | AKT3 | 0.31189886 |
150 | ABL2 | 0.31162394 |
151 | PRKACA | 0.30364310 |
152 | CDK15 | 0.30088924 |
153 | PDGFRB | 0.29943527 |
154 | FES | 0.28692964 |
155 | SRC | 0.28657416 |
156 | CDK11A | 0.27684497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.01010102 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.88743252 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.73561854 |
4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.54759541 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.99054481 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.96152601 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.95807091 |
8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.83592322 |
9 | Protein export_Homo sapiens_hsa03060 | 2.56075975 |
10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.22132942 |
11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.18744764 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.18600695 |
13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.18103471 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90918546 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90201746 |
16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81507190 |
17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.73322092 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72517210 |
19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72384712 |
20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63064350 |
21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57987755 |
22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57459282 |
23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.54615438 |
24 | Ribosome_Homo sapiens_hsa03010 | 1.46073294 |
25 | Shigellosis_Homo sapiens_hsa05131 | 1.44658641 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40644047 |
27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30471731 |
28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26129237 |
29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25516214 |
30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21921022 |
31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20345151 |
32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18440977 |
33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.17716347 |
34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17619555 |
35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16450434 |
36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13842976 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13639324 |
38 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.13012924 |
39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12839495 |
40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11584693 |
41 | Axon guidance_Homo sapiens_hsa04360 | 1.10989650 |
42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10414295 |
43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07186815 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02825285 |
45 | Adherens junction_Homo sapiens_hsa04520 | 1.02820958 |
46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.02093444 |
47 | Amoebiasis_Homo sapiens_hsa05146 | 1.01434716 |
48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98840923 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98077194 |
50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97165835 |
51 | Mineral absorption_Homo sapiens_hsa04978 | 0.96069712 |
52 | Tight junction_Homo sapiens_hsa04530 | 0.95197652 |
53 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94564471 |
54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93128571 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92001928 |
56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90957434 |
57 | * Alcoholism_Homo sapiens_hsa05034 | 0.87902536 |
58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86267048 |
59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.86157350 |
60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84943586 |
61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84061408 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.83996549 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82976487 |
64 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.82162600 |
65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79293649 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77669372 |
67 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.77408250 |
68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75435596 |
69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74859505 |
70 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.74509465 |
71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74093038 |
72 | Long-term depression_Homo sapiens_hsa04730 | 0.73367740 |
73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72080106 |
74 | Malaria_Homo sapiens_hsa05144 | 0.71337781 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69248029 |
76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68900431 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68658866 |
78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67870149 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67085874 |
80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66976805 |
81 | Melanoma_Homo sapiens_hsa05218 | 0.65832458 |
82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63981100 |
83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63761385 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61472541 |
85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60781880 |
86 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59573515 |
87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59475984 |
88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57118243 |
89 | Mismatch repair_Homo sapiens_hsa03430 | 0.56932326 |
90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56742628 |
91 | * GABAergic synapse_Homo sapiens_hsa04727 | 0.55429808 |
92 | Focal adhesion_Homo sapiens_hsa04510 | 0.55128817 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54951632 |
94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54272529 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54158089 |
96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53634868 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.51198324 |
98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51107867 |
99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50928434 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50564412 |
101 | Renin secretion_Homo sapiens_hsa04924 | 0.49999382 |
102 | Salmonella infection_Homo sapiens_hsa05132 | 0.49783755 |
103 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48881636 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46359390 |
105 | Salivary secretion_Homo sapiens_hsa04970 | 0.46349007 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44424775 |
107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42305920 |
108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41958531 |
109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41831918 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41734499 |
111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41533456 |
112 | Gap junction_Homo sapiens_hsa04540 | 0.39876722 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.38792724 |
114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38215488 |
115 | ABC transporters_Homo sapiens_hsa02010 | 0.37976377 |
116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37022110 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36527805 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36347764 |
119 | Peroxisome_Homo sapiens_hsa04146 | 0.36339680 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36159233 |
121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.35906842 |
122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35598247 |
123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35452833 |
124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35151177 |
125 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34716756 |
126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34318978 |
127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33811071 |
128 | Bile secretion_Homo sapiens_hsa04976 | 0.33684629 |
129 | Phototransduction_Homo sapiens_hsa04744 | 0.31871789 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31679642 |
131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30862346 |
132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30409540 |
133 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30218413 |
134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30049708 |
135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29955428 |
136 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.29805513 |
137 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29629824 |
138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29538642 |
139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28993820 |
140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28914431 |
141 | * Morphine addiction_Homo sapiens_hsa05032 | 0.28570929 |
142 | Melanogenesis_Homo sapiens_hsa04916 | 0.25471210 |
143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.24395244 |